APA

Arthur C., Jeffrey A., Yip E., Katsioulas V., Nalpantidis A., Kerridge I., Greenwood M., Coyle L., Mackinlay N., Fay K., Enjeti A., Shortt J. & Stevenson W. (20210427). Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. : Leukemia & lymphoma.

Chicago

Arthur Christopher, Jeffrey Anthony, Yip Eva, Katsioulas Vicki, Nalpantidis Anastasios, Kerridge Ian, Greenwood Matthew, Coyle Luke, Mackinlay Naomi, Fay Keith, Enjeti Anoop, Shortt Jake and Stevenson William. 20210427. Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. : Leukemia & lymphoma.

Harvard

Arthur C., Jeffrey A., Yip E., Katsioulas V., Nalpantidis A., Kerridge I., Greenwood M., Coyle L., Mackinlay N., Fay K., Enjeti A., Shortt J. and Stevenson W. (20210427). Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. : Leukemia & lymphoma.

MLA

Arthur Christopher, Jeffrey Anthony, Yip Eva, Katsioulas Vicki, Nalpantidis Anastasios, Kerridge Ian, Greenwood Matthew, Coyle Luke, Mackinlay Naomi, Fay Keith, Enjeti Anoop, Shortt Jake and Stevenson William. Prolonged administration of low-dose cytarabine and thioguanine in elderly patients with acute myeloid leukaemia (AML) achieves high complete remission rates and prolonged survival. : Leukemia & lymphoma. 20210427.